miR-505 suppresses prostate cancer progression by targeting NRCAM

Mostrar otras versiones (1)

Previous researchers have demonstrated that microRNA-505 (miR-505) is negatively correlated with progression in various malignancies. However, the detailed function and molecular mechanisms of miR-505 have yet to be completely elucidated in prostate cancer (PCa). The present study initially identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Xiao-Hui, Fu, Hao, Chen, Zhi-Yun, Lu, Jian-Ming, Zhuo, Yang-Jia, Chen, Jia-Hong, Zhong, Wei-De, Jia, Zhenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667922/
https://www.ncbi.nlm.nih.gov/pubmed/31322225
http://dx.doi.org/10.3892/or.2019.7231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667922/
https://www.ncbi.nlm.nih.gov/pubmed/31322225
http://dx.doi.org/10.3892/or.2019.7231

Ejemplares similares